Screen smarter.
Enroll faster.
Better trial enrollment begins before screening.
Biomarker-driven pre-screening — built on biomarker science to reduce screen failures and accelerate clinical trial enrollment.
Clinical Trial Enrollment Is Changing
Biomarker science is transforming clinical trial enrollment.
Sponsors still rely on costly site-based screening workflows associated with:
- High screen failure rates
- Operational burden
- Enrollment delays
SplashBIO™ was built for what comes next.
Screen Smarter.
Enroll Faster.
Built on biomarker science, SplashBIO enables biomarker-driven pre-screening before traditional site screening begins.
Reduce Screen Failures
Identify the right patients earlier.
Accelerate Enrollment
Move trials forward faster.
Lower Site Burden
Streamline operations for sites.
Improve Trial Readiness
Deliver biomarker-enriched, trial-ready participants.
Built for the
Biomarker Era
Accelerate Enrollment Timelines
Improve Enrollment Efficiency
Reduce Unnecessary Site Burden
Modernize Qualification Workflows
Launching First in Alzheimer's and Neurology Research
Starting in one of the most challenging areas of clinical research.
Built for what comes next across clinical research.
Better Trial Enrollment
Starts Earlier.
Let's modernize clinical trial enrollment together and unlock a new era of efficiency.